These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 986349)
21. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects. Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743 [TBL] [Abstract][Full Text] [Related]
22. [General pharmacological action of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (MCI-2016, bifemelane hydrochloride). Influence on respiratory and cardiovascular systems, renal function, autonomic nervous system, isolated smooth muscle and digestive organs]. Narimatsu A; Nakao K; Ikoma H; Egawa M; Kitada Y; Yamazaki S; Umezu K; Miyake M; Nishimura E; Hashimoto N Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):223-51. PubMed ID: 3754532 [TBL] [Abstract][Full Text] [Related]
23. General pharmacological properties of YJA20379-8, a new H+/K(+)-ATPase inhibitor with anti-ulcer activities. Lee EB; Cho SI; Chang HO; Chang MS; Kim KB; Lee SB; Choi WS Arzneimittelforschung; 2001; 51(8):659-66. PubMed ID: 11556127 [TBL] [Abstract][Full Text] [Related]
24. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide. Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002 [TBL] [Abstract][Full Text] [Related]
25. General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate. Part I: Effects on central nervous system and other properties. Kito G; Morimoto S; Shiomi M Arzneimittelforschung; 1996 Jun; 46(6):572-9. PubMed ID: 8767346 [TBL] [Abstract][Full Text] [Related]
26. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human). Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970 [TBL] [Abstract][Full Text] [Related]
27. General pharmacology of the new antimuscarinic compound vamicamide. Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084 [TBL] [Abstract][Full Text] [Related]
28. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. II. Effects on the peripheral system (author's transl)]. Ochiai T; Fukuchi I; Ego H; Yamamura M; Kudo Y; Ishida R Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):359-80. PubMed ID: 7327456 [TBL] [Abstract][Full Text] [Related]
29. General pharmacology of loracarbef in animals. Shetler T; Bendele A; Buening M; Clemens J; Colbert W; Deldar A; Helton D; McGrath J; Shannon H; Turk J Arzneimittelforschung; 1993 Jan; 43(1):60-70. PubMed ID: 8447851 [TBL] [Abstract][Full Text] [Related]
30. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide. Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167 [TBL] [Abstract][Full Text] [Related]